RGD peptide (GRGDNP) (TFA)

CAS No. ——

RGD peptide (GRGDNP) (TFA) ( —— )

Catalog No. M30010 CAS No. ——

RGD peptide (GRGDNP) (TFA) promote apoptosis through activation of conformation changes that enhance pro-caspase-3 activation and autoprocessing.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    RGD peptide (GRGDNP) (TFA)
  • Note
    Research use only, not for human use.
  • Brief Description
    RGD peptide (GRGDNP) (TFA) promote apoptosis through activation of conformation changes that enhance pro-caspase-3 activation and autoprocessing.
  • Description
    RGD peptide (GRGDNP) (TFA) promote apoptosis through activation of conformation changes that enhance pro-caspase-3 activation and autoprocessing.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    728.63
  • Molecular Formula
    C25H39F3N10O12
  • Purity
    >98% (HPLC)
  • Solubility
    H2O : ≥ 50 mg/mL (68.62 mM);DMSO : ≥ 50 mg/mL (68.62 mM)
  • SMILES
    ——
  • Chemical Name
    Sequence:{Gly}{Arg}{Gly}{Asp}{Asn}{Pro}

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Ruoslahti, E., and ?brink, B. Common principles in cell adhesion Experimental Cell Research 227, 1-11 (1996).
molnova catalog
related products
  • Thioacetamide

    Thioacetamide is a hepatotoxicant used widely to induce experimental liver lesions, develops hepatocellular necrosis and subsequent inflammation (mainly M1-/M2-macrophages without neutrophil infiltration) in rats.

  • Cassiaside B

    Cassiaside is a naphthyl ketone glycoside that inhibits BACE1 (IC50= 4.45 μM; Ki=9.85 μM).Cassiaside exhibits significant hepatoprotective effects against galactosamine injury and has potential anti-Alzheimer's disease (AD) activity.

  • BCAT-IN-4

    BCAT-IN-4 is a potent BCAT inhibitor with an IC50 value of 2.35 μM for hBCATc. BCAT-IN-4 has anticancer activity and can be used to study pancreatic ductal adenocarcinoma.